No

Corticosteroid, Topical

Inflammation of corticosteroid-responsive dermatoses [high potency topical corticosteroid]

C

Viral, fungal, or tubercular skin lesions, known hypersensitivity to halcinonide or any component

Adverse systemic effects may occur when used on large areas of the body, denuded areas, for prolonged periods of time, with an occlusive dressing, and/or in infants or small children

<1%: Itching, dry skin, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, skin atrophy, striae; local burning, irritation, miliaria; secondary infection

When consumed in excessive quantities, systemic hypercorticism and adrenal suppression may occur; in those cases, discontinuation and withdrawal of the corticosteroid should be done judiciously

No data reported

Decreases inflammation by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability

Absorption: Percutaneous absorption varies by location of topical application and the use of occlusive dressings

Metabolism: Primarily in the liver

Elimination: By the kidneys

Children and Adults: Topical: Apply sparingly 1-3 times/day, occlusive dressing may be used for severe or resistant dermatoses; a thin film of cream or ointment is effective; do not overuse. Therapy should be discontinued when control is achieved; if no improvement is seen, reassessment of diagnosis may be necessary.

None noted

None noted

No information available to require special precautions

No effects or complications reported

A thin film of cream or ointment is effective; do not overuse; do not use tight-fitting diapers or plastic pants on children being treated in the diaper area; use only as prescribed, and for no longer than the period prescribed; apply sparingly in light film; rub in lightly; avoid contact with eyes; notify physician if condition being treated persists or worsens

A thin film of cream or ointment is effective; do not overuse; do not use tight-fitting diapers or plastic pants on children being treated in the diaper area; use only as prescribed, and for no longer than the period prescribed; apply sparingly in light film; rub in lightly; avoid contact with eyes; notify physician if condition being treated persists or worsens

Cream (Halog®): 0.025% (15 g, 60 g, 240 g); 0.1% (15 g, 30 g, 60 g, 240 g)

Cream, emollient base (Halog®-E) : 0.1% (15 g, 30 g, 60 g)

Ointment, topical (Halog®): 0.1% (15 g, 30 g, 60 g, 240 g)

Solution (Halog®): 0.1% (20 mL, 60 mL)